FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

BiovaxID News

Most Popular BiovaxID Story

Lymphoma vaccine extends survival in late-stage study

In a study published in the online version of the Journal of Clinical Oncology, researchers at the University of Texas MD Anderson Cancer Center say a Phase III trial of the therapeutic vaccine Read more...

BiovaxID Press Releases

  • Biovest to Present on Regulatory Strategy for BiovaxID® Cancer Vaccine at MD Becker Cancer Immunotherapy Conference
  • Biovest Reports New BiovaxID® Cancer Vaccine Manufacturing Site Has Been Completed at its Minnesota Cell Culture Center
  • Cancer Vaccines Poised to Reach $3 Billion in Sales by 2015
  • Biovest to Present at ROTH Capital OC Growth Stock Conference
  • New Phase III Data Analysis for BiovaxID®, Personalized Lymphoma Vaccine, to Be Presented at ASH Annual Meeting

Latest Headlines